| miR-378a, miR-379, miR-139-5p, and miR-200b-5p |
Plasma |
Diagnostic biomarkers to differentiate adenocarcinoma and healthy subjects |
(39) |
| miR-19-3p, miR-21-5p and miR-221-3p |
Plasma |
Diagnostic biomarkers for lung adenocarcinoma |
(40) |
| miR-331-5p, miR-451a, miR-363-3p |
Plasma |
Diagnostic biomarkers for distinguishing SCLC from NSCLC |
(41) |
| miR-451a, miR-486-5p, miR-363-3p, miR-660-5p, miR-15b-5p, miR-25-3p and miR-16-2-3p |
Plasma |
Diagnostic biomarkers to differentiate adenocarcinoma from healthy subjects |
(41) |
| miR-126 |
Plasma |
Diagnostic biomarker for NSCLC |
(42) |
| miR-21, miR-205 and miR-155 |
Plasma |
Diagnostic biomarkers for early-stage NSCLC |
(43) |
| miR-let-7b-5p, miR-let-7e-5p, miR-23a-3p and miR-486-5p |
Plasma |
Diagnostic biomarkers of stage I NSCLC patients |
(44) |
| miR-181-5p, miR-30a3p, miR-30e-3p and miR-361-5p |
Plasma |
Diagnostic biomarkers for lung adenocarcinoma |
(44) |
| miR-10b-5p, miR-15b-5p and miR-320b |
Plasma |
Diagnostic biomarkers for SCC |
(44) |
| miR-205, miR-19a, miR-19b, miR-30b and miR-20a |
Plasma |
Diagnostic biomarkers for SCC after surgery |
(45) |
| miR-205-5p, miR-483-5p, miR-375, miR-200c-3p, miR-429, miR-200b-3p, miR-200a-3p, miR-203a-3p and miR-141-3p |
Pleural fluid |
Diagnostic biomarkers for discriminating lung adenocarcinoma over tuberculosis and other benign lesions |
(47,48) |
| miR-200 |
Pleural fluid |
Diagnostic biomarker for discriminating lung adenocarcinoma from benign effusions |
(49) |
| miR-182 and miR-210 |
Pleural fluid |
Diagnostic biomarkers for distinguishing lung adenocarcinoma from benign effusions |
(50) |
